Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.

about

Ferulic Acid Supplementation for Management of Depression in Epilepsy.Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs.

P2860

Q47858582-9E650E17-1E47-4585-A9EB-D45D96215C9D Q48363733-EEE0170F-6B32-452E-882A-A098C2D23338

P2860

Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.

Item

http://www.wikidata.org/entity/Q38856602

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.

@en

type

Item

label

Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.

@en

prefLabel

Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.

@en

P1476

Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities

@en

P2093

Kinga K Borowicz

http://www.w3.org/2001/XMLSchema#string

Monika Banach

http://www.w3.org/2001/XMLSchema#string

Monika Popławska

http://www.w3.org/2001/XMLSchema#string

Stanisław J Czuczwar

http://www.w3.org/2001/XMLSchema#string

P2860

Ketamine for the treatment of refractory status epilepticus

The role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibility

Preclinical antiepileptic actions of selective serotonin reuptake inhibitors--implications for clinical trial design

Biphasic effects of imipramine in experimental models of epilepsy

TASK-3 as a potential antidepressant target.

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta.

Rhythm and blues: animal models of epilepsy and depression comorbidity.

Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs.

Epilepsy, depression and antidepressant drugs.

P304

1067-1080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17425255.2016.1198319

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Błaszczyk

P577

2016-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27267259

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.

about

P2860

P2860

Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698